DK1037629T3 - Kombination af et retinsyremetabolismeblokerende middel og en tocopherol - Google Patents

Kombination af et retinsyremetabolismeblokerende middel og en tocopherol

Info

Publication number
DK1037629T3
DK1037629T3 DK98966615T DK98966615T DK1037629T3 DK 1037629 T3 DK1037629 T3 DK 1037629T3 DK 98966615 T DK98966615 T DK 98966615T DK 98966615 T DK98966615 T DK 98966615T DK 1037629 T3 DK1037629 T3 DK 1037629T3
Authority
DK
Denmark
Prior art keywords
tocopherol
combination
retinoic acid
blocking agent
acid metabolism
Prior art date
Application number
DK98966615T
Other languages
English (en)
Inventor
Porre Peter Marie-Zoe Rober De
Jan Paul Jozef Mich Bruynseels
Walter Boudewijn Leopo Wouters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1037629T3 publication Critical patent/DK1037629T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK98966615T 1997-12-19 1998-12-12 Kombination af et retinsyremetabolismeblokerende middel og en tocopherol DK1037629T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97204019 1997-12-19
PCT/EP1998/008127 WO1999032098A2 (en) 1997-12-19 1998-12-12 Combination of a ramba and a tocopherol
EP98966615A EP1037629B1 (en) 1997-12-19 1998-12-12 Combination of a retinoic acid metabolism blocking agent and a tocophereol

Publications (1)

Publication Number Publication Date
DK1037629T3 true DK1037629T3 (da) 2005-03-07

Family

ID=8229088

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98966615T DK1037629T3 (da) 1997-12-19 1998-12-12 Kombination af et retinsyremetabolismeblokerende middel og en tocopherol

Country Status (11)

Country Link
US (1) US6265425B1 (da)
EP (1) EP1037629B1 (da)
JP (1) JP2001526215A (da)
AT (1) ATE280578T1 (da)
AU (1) AU2413399A (da)
DE (1) DE69827295T2 (da)
DK (1) DK1037629T3 (da)
ES (1) ES2232034T3 (da)
PT (1) PT1037629E (da)
SI (1) SI1037629T1 (da)
WO (1) WO1999032098A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7636680B2 (en) * 2001-10-03 2009-12-22 Starmine Corporation Methods and systems for measuring performance of a security analyst
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
AU2004253967B2 (en) * 2003-07-03 2010-02-18 Cytovia, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
WO2006028970A1 (en) 2004-09-02 2006-03-16 Cengent Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
JP5685364B2 (ja) 2006-01-17 2015-03-18 スティーフェル・ラボラトリーズ・インコーポレーテッド トリアゾール化合物による炎症性疾患の処置
CA2643963A1 (en) * 2006-02-21 2007-08-30 Amgen Inc. Cinnoline derivatives as phosphodiesterase 10 inhibitors
US20100222275A1 (en) * 2007-10-19 2010-09-02 Kunihiko Tamaki Therapeutic agent for vitiligo and method of accelerating pigmentation

Also Published As

Publication number Publication date
DE69827295T2 (de) 2006-02-09
US6265425B1 (en) 2001-07-24
SI1037629T1 (en) 2005-04-30
JP2001526215A (ja) 2001-12-18
AU2413399A (en) 1999-07-12
EP1037629B1 (en) 2004-10-27
DE69827295D1 (de) 2004-12-02
PT1037629E (pt) 2005-03-31
WO1999032098A2 (en) 1999-07-01
ATE280578T1 (de) 2004-11-15
WO1999032098A3 (en) 1999-08-19
EP1037629A2 (en) 2000-09-27
ES2232034T3 (es) 2005-05-16

Similar Documents

Publication Publication Date Title
DK1037629T3 (da) Kombination af et retinsyremetabolismeblokerende middel og en tocopherol
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
DK0650483T3 (da) (3R,4R)-Delta6-tetrahydrocannabinol-7-syrer
EP2261200A3 (en) Modified forms of pharmacacologically active agents and uses therefor
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
DK1224172T3 (da) Medikamenter til behandling af ondartede tumorer
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
IT1285770B1 (it) Composti corticoidei
BR0013935A (pt) IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos
DK0988302T3 (da) Benzonaphthyridiner
ATE258797T1 (de) Verwendung von amifostin
DE60128100D1 (de) Analgetisches arzneimittel
AU2002332488A1 (en) R-bambuterol, its preparation and therapeutic uses
NO20012351L (no) Farmasoytisk sammensetning for modifisert frigjoring av insulinsensibiliserende middel
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
DK0986386T3 (da) Anvendelse af nitrogenheterocycliske, aromatiske derivater til topisk behandling af sygdomme i epitelvævene
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
SE9800905L (sv) Ny terapi vid glomerulonefrit
NO20023111L (no) Utvortes preparat for behandling av pruritus
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet